Proton Beam Therapy alone for Intermediate- or high-risk prostate cancer: an institutional prospective cohort study

The role of proton beam therapy as monotherapy for localised prostate cancer remains unclear. The purpose of this study was to evaluate the efficacy and adverse events of proton beam therapy alone for these patients.
MDPI-Cancers